Equecabtagene Autoleucel
IASO Biotherapeutics
['multiple myeloma', 'iaso bio', 'innovent']
sfbn feed: iaso bio and innovent updated efficacy and safety clinical data of equecabtagene autoleucel bcma car-t cell therapy for multiple myeloma at the 2023 asco annual meeting: shanghai and nanjing, ... #bayarea #biotech 
San Francisco Biotechnology News and Events, follow jobs at @sfbnjobs